Latest news
Lilly's weight-loss pill gets UK regulator's nod - ReutersReuters · Mon, 10 Aug 2026 15:21:04 GMTStockWatch: Lilly Rises on Revenue Leap; Analysts High on Krystal Despite Revenue Miss - Genetic Engineering and Biotechnology NewsGenetic Engineering and Biotechnology News · Mon, 10 Aug 2026 04:37:02 GMTBetter GLP-1 Stock to Buy: Eli Lilly or Viking Therapeutics? - The Motley FoolThe Motley Fool · Sat, 08 Aug 2026 20:30:00 GMTEli Lilly and Company Q2 Earnings Call Highlights - TradingViewTradingView · Sat, 08 Aug 2026 16:04:04 GMTEli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 22:50:00 GMTThomas Marron of Eli Lilly to present at the 13th Aging Research & Drug Discovery (ARDD) meeting in Boston - EurekAlert!EurekAlert! · Fri, 07 Aug 2026 18:23:10 GMTYour Questions Answered: The Biggest Pharma Stories of the Week of August 3-7, 2026 - Pharmaceutical ExecutivePharmaceutical Executive · Fri, 07 Aug 2026 10:07:38 GMTThe Oral GLP-1 Tracker: Lilly's Foundayo builds scripts after disappointing Q2 - Fierce PharmaFierce Pharma · Fri, 07 Aug 2026 07:00:00 GMT